Alexander Chi, MD Involved in Groundbreaking Lung Cancer Treatment Studies

CHARLESTON, W.Va., March 27, 2015 /True Blue Tribune/ — West Virginia University thoracic radiation oncologist Alexander Chi, MD is currently the principal investigator on a potentially groundbreaking research study; a phase II clinical trial that is looking at the role of stereo-tactic ablative radiotherapy, or SABR, in the treatment of bulkier non-small cell lung cancer (NSCLC). As a professional with special expertise in stereo-tactic ablative radiotherapy, what is more commonly known as stereo-tactic body radiation therapy (SBRT) for the treatment of thoracic malignancies, Dr. Chi is excited about the potential outcome of the study, which, he believes, could one day lead to an all new way of providing definitive treatment to NSCLC patients in the near future.

Alexander Chi, MD, known as a very academically minded physician and translational researcher, is the principal investigator on two current research trials. The first is a phase II clinical trial involving the study of SABR’s role in the treatment of large, early stage non-small cell lung cancer, involving, according to Chi, the delivery of a higher than conventionally accepted Biologically Effective Dose, or BED. The second is a phase I clinical trial that is investigating the potential role of a stereo-tactic boost, delivered before or after concurrent chemo-radiation, in the treatment of locally advanced NSCLC.

Both trials, according to Alexander Chi, MD, are very important in the attempt to validate the use of advanced technology: intensity modulated, image-guided photon therapy for dose escalation as part of the treatment of local-regionally confined NSCLC. In addition to this, he says, predictive biomarkers in human tumor tissue and peripheral blood are sought to identify individuals who may truly benefit from dose escalation, as well as individuals who may be in need of further systemic therapy to individualize complex treatment strategies based on each individual’s unique genetic profile.

Both clinical trials are currently underway, and, according to Alexander Chi, MD, could have potentially groundbreaking consequences in the near future. Dr. Chi is optimistic that these studies will provide a new and effective way to treat patients with non-small cell lung cancer.

About Alexander Chi, MD

Alexander Chi, MD is enthusiastically pursuing more effective treatments for patients suffering with NSCLC.

WGU Washington Celebrates Nurses with New Scholarship Program

SEATTLE, March 27, 2015 /True Blue Tribune/ — To honor nurses for their commitment to high-quality healthcare delivery and to commemorate upcoming National Nurses Week, WGU Washington has announced the WGU Washington Loves Nurses Scholarship. During the week of May…

Medical Affairs Capabilities Expanding in Emerging Marketplaces

CHAPEL HILL, N.C., March 27, 2015 /True Blue Tribune/ — Across the global healthcare landscape, the Medical Affairs function is essential to meeting challenges in clinical development, market education, and regulatory compliance. As emerging markets develop and face tighter regulations,…

New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies

CHAPEL HILL, N.C., March 27, 2015 /True Blue Tribune/ — The quality function within the medical device sector carries an intimidating job description: ensure products meet quality standards at every stage of the product life cycle. Facing tight budgets and…

Small Cap IR Correction — BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.

NEW YORK, March 27, 2015 /True Blue Tribune/ — BioCorRx, Inc. (BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S.…

Ellen Pao May Lose On Gender Discrimination Claims But Jury Undecided On Retaliation

The jury in Ellen Pao’s gender discrimination lawsuit against Kleiner Perkins appeared to find that she did not face discrimination but could not come to an agreement on her retaliation claim. (AP/Eric Risberg) Ellen Pao failed to persuade jurors that…

MSG Splits Knicks, Rangers And Garden From Regional Sports Network’s

The Madison Square Garden Company, owner of the New York Knicks, Rangers and Madison Square Garden sports arena said on Friday it will split off its sports and entertainment business from its media operations, which include MSG Network and MSG+.…

In The Wake Of Germanwings, Airlines Rush To Adopt The ‘Rule Of Two’

When the tragic details of this week’s Germanwings crash became known, among the first questions asked was, “Why was there only one pilot in the cockpit?” Now, European airlines are rushing to adopt procedures that require two people up front…

Covalon Announces Issuance of Stock Options

MISSISSAUGA, ON, March 27, 2015 /CNW/ – Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV), an advanced medical technologies company, today announced the issuance of an aggregate of 30,000 stock options to six independent directors of the Company and…

The North Face and November Project Team Up to Offer Free Workouts in Five Cities

ALAMEDA, Calif., March 27, 2015 /True Blue Tribune/ — The North Face is joining the free fitness movement by bringing Mountain Athletics workouts to five cities across the country, and making it that much easier to train for a goal. …